Cassava Sciences | PTIE - Dochód Netto





Dochód Netto Zmiana Data
Abbott USD 1.08B 699M 2026-03
Amgen USD 1.82B 486M 2026-03
Biogen USD 319.5M 368.4M 2026-03
Cara Therapeutics USD -5.53M 621K 2025-09
Cassava Sciences USD -12.54M 1.73M 2025-12
Eisai JPY -3.25B 20.43B 2026-03
Eli Lilly USD 7.4B 760M 2026-03
Geron USD -3.64M 27.5M 2026-03
J&J USD 5.24B 119M 2026-03
Merck USD -4.24B 7.2B 2026-03
Novartis USD 3.16B 747M 2026-03
Novavax USD 17.53M 219.91M 2025-12
Pfizer USD 2.69B 4.34B 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12